Incidences of Deep Molecular Responses and Treatment-Free Remission in de Novo CP-CML Patients

Background: Tyrosine Kinase Inhibitors (TKIs) discontinuation in patients who had achieved a deep molecular response (DMR) offer now the opportunity of prolonged treatment-free remission (TFR). Patients and Methods: Aims of this study were to evaluate the proportion of de novo chronic-phase chronic...

Ausführliche Beschreibung